What Are GLP-1 Medications? A Beginner's Guide to How They Work

## What Is GLP-1? The Basics in Plain Language GLP-1 stands for glucagon-like peptide-1. It is a hormone your body naturally produces in your gut every time you eat. Its main jobs are straightforward: tell your brain you are full, signal your pancreas to release insulin, and slow down how fast food leaves your stomach. Think of GLP-1 as a dimmer switch for hunger. After a meal, your body turns the switch down so you stop feeling hungry. The problem is that in many people — especially those with obesity or type 2 diabetes — this dimmer switch does not work well enough. Food cravings stay on full blast even when your body has had enough fuel. GLP-1 medications are synthetic versions of this natural hormone, engineered to last much longer in your body. While your natural GLP-1 breaks down within minutes, these medications stay active for days, keeping that hunger dimmer turned down around the clock. ## How GLP-1 Medications Work in Your Body Here is a simple breakdown of what happens when you take a GLP-1 medication: ### Step 1: Appetite Reduction The medication crosses into your brain and activates GLP-1 receptors in the hypothalamus — the region that controls hunger and satiety. The result is a significant reduction in appetite and what patients often describe as "food noise," those persistent background thoughts about what to eat next. ### Step 2: Slower Digestion GLP-1 medications slow gastric emptying, meaning food stays in your stomach longer. This creates a prolonged feeling of fullness after smaller meals. Instead of feeling hungry two hours after lunch, you might not think about food for four or five hours. ### Step 3: Better Blood Sugar Control When you eat, the medication tells your pancreas to release insulin in a glucose-dependent manner — meaning it only increases insulin when your blood sugar is actually elevated. This is why GLP-1 medications rarely cause dangerous low blood sugar (hypoglycemia) on their own. ### Step 4: Reduced Reward Eating Emerging research suggests GLP-1 medications also affect the brain's reward pathways. Many patients report that high-calorie foods like pizza, candy, and chips simply become less appealing. You can still eat them, but the compulsive drive to overeat diminishes. ## Types of GLP-1 Medications Available The GLP-1 medication landscape has expanded significantly. Here are the main options: | Medication | Brand Names | How It Works | Typical Weight Loss | Dosing | |-----------|-------------|-------------|-------------------|--------| | Semaglutide | Wegovy, Ozempic | GLP-1 receptor agonist | 10-15% body weight | Weekly injection | | Tirzepatide | Mounjaro, Zepbound | Dual GLP-1 + GIP agonist | 15-22% body weight | Weekly injection | | Retatrutide | (Phase 3 trials) | Triple GLP-1 + GIP + glucagon agonist | Up to 24% body weight | Weekly injection | | Oral semaglutide | Rybelsus | GLP-1 receptor agonist (pill form) | 8-12% body weight | Daily pill | | Liraglutide | Saxenda | GLP-1 receptor agonist | 5-8% body weight | Daily injection | ### Semaglutide: The Most Widely Used Semaglutide is the medication behind the brand names Ozempic (for type 2 diabetes) and Wegovy (for weight management). It was the first GLP-1 to gain mainstream attention and has the longest track record in weight management studies. In the landmark STEP 1 trial, participants lost an average of 14.9% of their body weight over 68 weeks. Semaglutide is a once-weekly injection, and the dose gradually increases over 16-20 weeks to minimize side effects. For more detail, see our [semaglutide dosing schedule guide](/guides/semaglutide-dosing-schedule-week-by-week-guide). ### Tirzepatide: The Dual-Action Option Tirzepatide targets two hormone receptors instead of one — both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual mechanism produced the highest weight loss results seen in any obesity medication trial. In the SURMOUNT-1 study, participants on the highest dose lost an average of 22.5% of their body weight. The dosing schedule for tirzepatide follows a similar gradual approach. Read our [tirzepatide dosing guide](/guides/tirzepatide-dosing-schedule-complete-guide) for the full breakdown. ### Retatrutide: The Triple Agonist Retatrutide is the newest and most powerful option in this class. It targets three receptors: GLP-1, GIP, and glucagon. In Phase 2 trials published in the New England Journal of Medicine (2023), participants lost up to 24.2% of their body weight at 48 weeks. As of 2026, retatrutide is in Phase 3 clinical trials, and compounded versions are available through licensed pharmacies. Learn more in our [retatrutide guide](/guides/retatrutide-weight-loss-triple-agonist-guide-2026). ## Who Are GLP-1 Medications For? GLP-1 medications are FDA-approved for: - **Adults with obesity** (BMI of 30 or higher) - **Adults who are overweight** (BMI of 27 or higher) with at least one weight-related health condition such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea - **Adults with type 2 diabetes** for blood sugar management (semaglutide, tirzepatide, liraglutide) They are also being studied for additional conditions including non-alcoholic fatty liver disease (NAFLD), polycystic ovary syndrome (PCOS), and cardiovascular risk reduction. ## Who Should NOT Take GLP-1 Medications These medications are not for everyone. You should avoid GLP-1 medications if you: - Have a personal or family history of **medullary thyroid carcinoma** (MTC) or **Multiple Endocrine Neoplasia syndrome type 2** (MEN2) - Have a history of **severe pancreatitis** - Are **pregnant, planning to become pregnant**, or breastfeeding - Have **gastroparesis** (severely delayed stomach emptying) that is already symptomatic - Have a known allergy to the active ingredient or any component of the formulation Always disclose your full medical history to your prescribing provider. For more on safety, read our [semaglutide side effects management guide](/guides/semaglutide-side-effects-how-to-manage). ## What Do GLP-1 Medications Cost? Cost is one of the biggest barriers to accessing GLP-1 medications. Here is a general overview: | Option | Approximate Monthly Cost | Notes | |--------|------------------------|-------| | Brand-name Wegovy/Ozempic | $800-$1,300 | With insurance, copays vary widely ($25-$300) | | Brand-name Mounjaro/Zepbound | $800-$1,200 | Insurance coverage expanding in 2026 | | Compounded semaglutide | $150-$350 | Available through compounding pharmacies | | Compounded tirzepatide | $200-$450 | Available through compounding pharmacies | | Compounded retatrutide | $250-$500 | Limited availability | Compounded versions contain the same active ingredient but are manufactured by licensed compounding pharmacies rather than the brand-name manufacturer. They are significantly more affordable and are legally available when the brand-name product is in shortage or when a physician prescribes a customized dose. For a deeper cost comparison, see our [semaglutide cost guide](/guides/semaglutide-cost-price-guide-2026) and [tirzepatide cost guide](/guides/tirzepatide-cost-price-guide-2026). ## How to Get Started with GLP-1 Medications Getting started is more straightforward than most people think: ### 1. Consult a Healthcare Provider You need a prescription. This can come from your primary care doctor, an endocrinologist, an obesity medicine specialist, or a licensed telehealth provider. Be honest about your weight history, current medications, and health goals. ### 2. Get Baseline Lab Work Your provider will typically order fasting blood glucose, HbA1c, lipid panel, liver function, kidney function, and thyroid markers. These serve as your baseline and help rule out contraindications. ### 3. Choose Your Medication Based on your health profile, budget, and insurance coverage, your provider will recommend a specific medication. If cost is a concern, compounded versions may be a viable option worth discussing. ### 4. Start Low and Go Slow All GLP-1 medications use a gradual dose-escalation approach. You will start at the lowest dose and increase every 4 weeks as tolerated. This minimizes side effects, especially nausea. ### 5. Pair with Lifestyle Changes GLP-1 medications work best when combined with proper nutrition and regular physical activity. They reduce appetite, but they do not choose your food for you. Focusing on adequate protein intake and resistance training will help ensure the weight you lose is predominantly fat. Check out our [GLP-1 diet guide](/guides/what-to-eat-on-glp1-medications-diet-guide) and [exercise guide](/guides/semaglutide-and-exercise-workout-guide) for specifics. ## Common Side Effects to Expect The most frequently reported side effects are gastrointestinal and tend to be worst during the first few weeks of each dose increase: - **Nausea** (30-45% of patients, usually mild to moderate) - **Constipation or diarrhea** (15-25%) - **Bloating and gas** (10-20%) - **Mild headache** (5-10%) - **Fatigue** during the first 1-2 weeks For most people, these side effects are temporary and manageable. Eating smaller meals, staying hydrated, and following the slow dose-escalation protocol significantly reduces their severity. ## The Bottom Line GLP-1 medications represent a genuine breakthrough in treating obesity and metabolic disease. They work by amplifying your body's own hunger-regulation system, making it easier to eat less without the constant battle of willpower. They are not magic pills — lifestyle changes still matter — but they give your body the biochemical support it needs to lose weight and keep it off. If you are considering GLP-1 therapy, the most important step is talking to a qualified healthcare provider who can evaluate whether these medications are right for your specific situation. ## References - [Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)](https://www.nejm.org/doi/full/10.1056/NEJMoa2032183). *New England Journal of Medicine*, 2021. - [Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)](https://www.nejm.org/doi/full/10.1056/NEJMoa2206038). *NEJM*, 2022. - [Retatrutide Phase 2 Obesity Trial](https://www.nejm.org/doi/full/10.1056/NEJMoa2301972). *NEJM*, 2023. - [GLP-1 Receptor Agonists — Mechanisms of Action and Clinical Use](https://pubmed.ncbi.nlm.nih.gov/33990377/). *Nature Reviews Endocrinology*, 2021. - [FDA Approves Wegovy for Chronic Weight Management](https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management). *U.S. FDA*, 2021.